D-0408-2024 Class II Terminated

Recalled by SCA Pharmaceuticals, LLC — Windsor, CT

FDA drug recall D-0408-2024 was initiated by SCA Pharmaceuticals, LLC on Nov 9, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Aug 27, 2024). Affected quantity: 399 syringes.

Recall Details

Product Type
Drugs
Report Date
Apr 3, 2024
Initiation Date
Nov 9, 2023
Termination Date
Aug 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
399 syringes

Product Description

HYDROmorphone HCl 25 mg/25 mL in 0.9% Sodium Chloride Injection, (Concentration = 1mg/mL), 25 mL fill 30 mL Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0303-17, Bar Code 7004030317

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: 1223048491 Exp 11/21/23

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0408-2024
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0408-2024. Report a data issue: hello@regdatalab.com.